Commentary: Drug Comparisons and Contact Allergy in AD, February 2024January 24, 2024Atopic Dermatitis
Dermatology NewsA Look at the Evidence Linking Diet to Skin ConditionsJanuary 22, 2024AcneAtopic DermatitisRosaceaPsoriasisPsoriatic ArthritisPediatrics
Dermatology NewsNovel Clinic Resulted in ‘Impressive’ Outcomes for Patients With Moderate to Severe EczemaJanuary 22, 2024Atopic DermatitisBusiness of MedicinePediatrics
Men with atopic dermatitis more likely to have poorer cognitive functionJanuary 10, 2024Atopic Dermatitis
Atopic dermatitis is associated with increased prevalence of inflammatory bowel diseaseJanuary 10, 2024Atopic Dermatitis
Real-world study confirms the multidimensional efficacy of tralokinumab in atopic dermatitisJanuary 10, 2024Atopic Dermatitis
Abrocitinib downregulates genes associated with atopic dermatitis pathologyJanuary 10, 2024Atopic Dermatitis
Rapid and sustained improvement in skin pain with abrocitinib in atopic dermatitisJanuary 10, 2024Atopic Dermatitis
Allergic contact dermatitis a crucial comorbidity in atopic dermatitisJanuary 10, 2024Atopic Dermatitis
Aggregate response benefit in skin clearance and itch reduction favor upadacitinib over dupilumab in ADJanuary 10, 2024Atopic Dermatitis
Interim analysis confirms the safety and efficacy of dupilumab in atopic dermatitis January 10, 2024Atopic Dermatitis
Atopic dermatitis not linked with increased venous thromboembolism riskJanuary 10, 2024Atopic Dermatitis
Atopic dermatitis not linked with increased venous thromboembolism riskJanuary 10, 2024Atopic Dermatitis
Dermatology NewsAAAAI/ACAAI Joint Task Force Issues Updated ‘Practice-Changing’ Guidelines to Manage ADJanuary 8, 2024Atopic DermatitisPediatrics
